Journals / European journal of rhinology and allergy (Online) / 2020 / Cilt: 3 - Sayı: 3

New Index for the Discriminationof Acute StreptococcalTonsillopharyngitis and InfectiousMononucleosis: InfectionDiscrimination Index

Pages
64–68
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The IDI means of the three groups were significantly different (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to discriminate group A β-hemolytic streptococcus (GABHS) and Epstein-Barr virus (EBV) that cause acute tonsillopharyngitis with a new index called the infection discrimination index (IDI).Material and Methods: Based on the throat culture and viral capsid Ag Ig M results, 110 GABHS-positive children and 52 EBV-positive children were enrolled in the GABHS and EBV groups, respectively.
📊
Key Findings & Data:The IDI means of the three groups (GABHS, EBV, control) were subjected to a statistical comparison.Results: The groups did not significantly differ in terms of sex and age (p: 0.453 and 0.662, respectively).
💡
Conclusion & Impact:The IDI means of the three groups were significantly different (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to discriminate group A β-hemolytic streptococcus (GABHS) and Epstein-Barr virus (EBV) that cause acute tonsillopharyngitis with a new index called the infection discrimination index (IDI).Material and Methods: Based on the throat culture and viral capsid Ag Ig M results, 110 GABHS-positive children and 52 EBV-positive children were enrolled in the GABHS and EBV groups, respectively. Fifty children who had undergone a medical examination at the pediatric clinic comprised the control group. The IDI means of the three groups (GABHS, EBV, control) were subjected to a statistical comparison.Results: The groups did not significantly differ in terms of sex and age (p: 0.453 and 0.662, respectively). The IDI means of the three groups were significantly different (p

🔖

Cite This Article

ÇETİN, H., SİVRİCE, M. E., YASAN, H., KUMBUL, Y. Ç., AKIN, V. (2022). New Index for the Discriminationof Acute StreptococcalTonsillopharyngitis and InfectiousMononucleosis: InfectionDiscrimination Index. European journal of rhinology and allergy (Online), Cilt: 3 - Sayı: 3, 64–68. https://ajindex.com/articles/511909

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005
  2. [Crossref] 2. Wiatrak BJ, Woolley AL. Pharyngitis and adenotonsillar disease. Cummings CW, editor. Otolaryngology-Head and Neck Surgery. 4th ed. Philadelphia: Mosby Inc
  3. p.2782-802. 3. Hallee TJ, Evans AS, Niederman JC, Brooks CM, Voegtly H. Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J Biol Med 1974
  4. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012
  5. e86-102. [Crossref] 5. Pichichero ME. Group A streptococcal tonsillopharyngitis: Cost-effective diagnosis and treatment. Ann Emerg Med 1995
  6. [Crossref] 6. Tsevat J, Kotagal UR. Management of sore throats in children: A cost-effectiveness analysis. Arch Pediatr Adolesc Med 1999
  7. [Crossref] 7. Patel C, Green BD, Batt JM, Kholmurodova F, Barnes M, Geyer WJ, et al. Antibiotic prescribing for tonsillopharyngitis in a general practice setting: Can the use of modified centor criteria reduce antibiotic prescribing?. Aust J Gen Pract 2019
  8. [Crossref] 8. Balfour JHH, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 2013
  9. [Crossref] 9. Dowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One 2013
  10. 64921. [Crossref] 10. Jenson HB. Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr 2000
  11. [Crossref] 11. PubMed-NCBI [Internet]. 2020. [cited 2020 Apr 29]. Available from: https:// www.ncbi.nlm.nih.gov/pubmed/ 12. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol 2004
  12. [Crossref] 13. Topp SK, Rosenfeldt V, Vestergaard H, Christiansen CB, Von Linstow ML. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection. Infect Dis (Lond) 2015
  13. [Crossref] 14. Wolf DM, Friedrichs